-
1
-
-
84855593292
-
-
AAPCC (American Association of Poison Control Center).
-
AAPCC (American Association of Poison Control Center). http://www.aapcc.org/.
-
-
-
-
2
-
-
33947127824
-
Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users
-
Alho H., Sinclair D., Vuori E., Holopainen A. Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users. Drug Alcohol Depend. 2007, 88:75-78.
-
(2007)
Drug Alcohol Depend.
, vol.88
, pp. 75-78
-
-
Alho, H.1
Sinclair, D.2
Vuori, E.3
Holopainen, A.4
-
3
-
-
0038663019
-
Postmarketing surveillance for drug abuse
-
Arfken C., Cicero T. Postmarketing surveillance for drug abuse. Drug Alcohol Depend. 2003, 70:S97-S105.
-
(2003)
Drug Alcohol Depend.
, vol.70
-
-
Arfken, C.1
Cicero, T.2
-
4
-
-
0037371928
-
Postmarketing surveillance of abuse liability of sibutramine
-
Arfken C., Schuster C., Johanson C.-E. Postmarketing surveillance of abuse liability of sibutramine. Drug Alcohol Depend. 2003, 69:169-173.
-
(2003)
Drug Alcohol Depend.
, vol.69
, pp. 169-173
-
-
Arfken, C.1
Schuster, C.2
Johanson, C.-E.3
-
5
-
-
77955095276
-
Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: national surveys of physicians
-
Arfken C., Johanson C.-E., di Menza S., Schuster C. Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: national surveys of physicians. J. Subst. Abuse Treat. 2010, 39:96-104.
-
(2010)
J. Subst. Abuse Treat.
, vol.39
, pp. 96-104
-
-
Arfken, C.1
Johanson, C.-E.2
di Menza, S.3
Schuster, C.4
-
6
-
-
0030696977
-
Response rates to mail surveys published in medical journals
-
Asch D., Jedrziewski M., Christakis N. Response rates to mail surveys published in medical journals. J. Clin. Epidemiol. 1997, 50:1129-1136.
-
(1997)
J. Clin. Epidemiol.
, vol.50
, pp. 1129-1136
-
-
Asch, D.1
Jedrziewski, M.2
Christakis, N.3
-
7
-
-
2342590729
-
French field experience with buprenorphine
-
Auriacombe M., Fatsea M., Dubernet J., Daulouede J., Tignol J. French field experience with buprenorphine. Am. J. Addict. 2001, 13(Suppl. 1):S17-S28.
-
(2001)
Am. J. Addict.
, vol.13
, Issue.SUPPL. 1
-
-
Auriacombe, M.1
Fatsea, M.2
Dubernet, J.3
Daulouede, J.4
Tignol, J.5
-
8
-
-
27244452980
-
Potential for abuse of buprenorphine in office-based treatment of opioid dependence
-
Cicero T., Inciardi J. Potential for abuse of buprenorphine in office-based treatment of opioid dependence. N. Engl. J. Med. 2005, 353:1863-1865.
-
(2005)
N. Engl. J. Med.
, vol.353
, pp. 1863-1865
-
-
Cicero, T.1
Inciardi, J.2
-
9
-
-
25844526549
-
Trends in abuse of oxycontin and other opioid analgesics in the United States: 2002-2004
-
Cicero T., Inciardi J., Munoz A. Trends in abuse of oxycontin and other opioid analgesics in the United States: 2002-2004. J. Pain 2005, 6:662-672.
-
(2005)
J. Pain
, vol.6
, pp. 662-672
-
-
Cicero, T.1
Inciardi, J.2
Munoz, A.3
-
10
-
-
27744513872
-
Comparison of intravenous buprenorphine and methadone self-administration by recently detoxified heroin-dependent individuals
-
Comer S., Sullivan M., Walker E. Comparison of intravenous buprenorphine and methadone self-administration by recently detoxified heroin-dependent individuals. J. Pharmacol. Exp. Ther. 2005, 315:1320-1330.
-
(2005)
J. Pharmacol. Exp. Ther.
, vol.315
, pp. 1320-1330
-
-
Comer, S.1
Sullivan, M.2
Walker, E.3
-
11
-
-
29244473555
-
Major increases in opioid analgesic abuse in the United States: concerns and strategies
-
Compton W., Volkow N. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend. 2006, 81:103-107.
-
(2006)
Drug Alcohol Depend.
, vol.81
, pp. 103-107
-
-
Compton, W.1
Volkow, N.2
-
12
-
-
77955165148
-
Post-marketing surveillance of methadone and buprenorphine in the United States
-
Dasgupta N., Bailey E., Cicero T., Inciardi J., Parrino M., Rosenblum A., Dart R. Post-marketing surveillance of methadone and buprenorphine in the United States. Pain Med. 2010, 11:1078-1091.
-
(2010)
Pain Med.
, vol.11
, pp. 1078-1091
-
-
Dasgupta, N.1
Bailey, E.2
Cicero, T.3
Inciardi, J.4
Parrino, M.5
Rosenblum, A.6
Dart, R.7
-
13
-
-
84855596106
-
-
Office of Applied Studies, Substance Abuse, Mental Health Services Administration, Rockville, MD, DAWN
-
DAWN Drug Abuse Warning Network, 2004-2009: Detailed Tables: National Estimates, Drug-related Emergency Department Visits, All Drug Misuse and Abuse Visits by Drug 2009, Office of Applied Studies, Substance Abuse, Mental Health Services Administration, Rockville, MD. http://dawninfo.samhsa.gov/data/default.asp?met=All.
-
(2009)
Drug Abuse Warning Network, 2004-2009: Detailed Tables: National Estimates, Drug-related Emergency Department Visits, All Drug Misuse and Abuse Visits by Drug
-
-
-
14
-
-
84855607295
-
-
DAWN. The DAWN report: trends in emergency department visits involving nonmedical use of narcotic pain relievers. (18.06.10).
-
DAWN, 2010. The DAWN report: trends in emergency department visits involving nonmedical use of narcotic pain relievers. (18.06.10). http://oas.samhsa.gov/2k10/DAWN016/OpioidED.cfm.
-
(2010)
-
-
-
15
-
-
0037068511
-
Clinical practice. Office-based treatment of opioid-dependent patients
-
Fiellin D., O'Connor P. Clinical practice. Office-based treatment of opioid-dependent patients. N. Engl. J. Med. 2002, 347:817-823.
-
(2002)
N. Engl. J. Med.
, vol.347
, pp. 817-823
-
-
Fiellin, D.1
O'Connor, P.2
-
16
-
-
33746387027
-
Counseling plus buprenophine-naloxone maintenance therapy for opioid dependence
-
Fiellin D.A., Pantalon M.V., Chawarski M.C., Moore B.A., Sullivan L.D., O'Connor P.G., Schottenfeld R.S. Counseling plus buprenophine-naloxone maintenance therapy for opioid dependence. N. Engl. J. Med. 2006, 355:365-374.
-
(2006)
N. Engl. J. Med.
, vol.355
, pp. 365-374
-
-
Fiellin, D.A.1
Pantalon, M.V.2
Chawarski, M.C.3
Moore, B.A.4
Sullivan, L.D.5
O'Connor, P.G.6
Schottenfeld, R.S.7
-
17
-
-
0042360208
-
Office-based treatment of opiate addicition with a sublingual-table of buprenorphine and naloxone
-
The Buprenorphine/Naloxone Collaborative Study Group
-
Fudula P.J., Bridge T.P., Herber S., Williford W.O., Chiang C.N., Jones K., Collins J., Raisch D., Casadonte P., Goldsmith R.J., Ling W., Malkerneker U., McNicholas L., Renner J., Stine S., Tusel D., The Buprenorphine/Naloxone Collaborative Study Group Office-based treatment of opiate addicition with a sublingual-table of buprenorphine and naloxone. N. Engl. J. Med. 2003, 349:949-958.
-
(2003)
N. Engl. J. Med.
, vol.349
, pp. 949-958
-
-
Fudula, P.J.1
Bridge, T.P.2
Herber, S.3
Williford, W.O.4
Chiang, C.N.5
Jones, K.6
Collins, J.7
Raisch, D.8
Casadonte, P.9
Goldsmith, R.J.10
Ling, W.11
Malkerneker, U.12
McNicholas, L.13
Renner, J.14
Stine, S.15
Tusel, D.16
-
18
-
-
0021101831
-
Temgesic abuse
-
Harper I. Temgesic abuse. N. Z. Med. J. 1983, 96:777.
-
(1983)
N. Z. Med. J.
, vol.96
, pp. 777
-
-
Harper, I.1
-
19
-
-
54049148442
-
-
JBS International, Inc., Silver Spring, MD, JBS International, Inc.
-
JBS International, Inc. Diversion and Abuse of Buprenorphine: A Brief Assessment of Emerging Indicators 2006, JBS International, Inc., Silver Spring, MD.
-
(2006)
Diversion and Abuse of Buprenorphine: A Brief Assessment of Emerging Indicators
-
-
-
20
-
-
0018147760
-
Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction
-
Jasinski D., Pevnick J., Griffith J. Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction. Arch. Gen. Psychiatry 1978, 35:501-516.
-
(1978)
Arch. Gen. Psychiatry
, vol.35
, pp. 501-516
-
-
Jasinski, D.1
Pevnick, J.2
Griffith, J.3
-
21
-
-
13844297152
-
Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue?
-
Jenkinson R., Clark N., Fry C., Dobbin M. Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue?. Addiction 2005, 100:197-205.
-
(2005)
Addiction
, vol.100
, pp. 197-205
-
-
Jenkinson, R.1
Clark, N.2
Fry, C.3
Dobbin, M.4
-
22
-
-
0026539226
-
A controlled trial of buprenorphine treatment for opioid dependence
-
Johnson R., Jaffe J., Fudala P. A controlled trial of buprenorphine treatment for opioid dependence. JAMA 1992, 267:2750-2755.
-
(1992)
JAMA
, vol.267
, pp. 2750-2755
-
-
Johnson, R.1
Jaffe, J.2
Fudala, P.3
-
23
-
-
0026051960
-
The use of buprenorphine and temazepam by drug injectors
-
Lavelle T., Hammersley R., Forsyth A., Bain D. The use of buprenorphine and temazepam by drug injectors. J. Addict. Dis. 1991, 10:5-14.
-
(1991)
J. Addict. Dis.
, vol.10
, pp. 5-14
-
-
Lavelle, T.1
Hammersley, R.2
Forsyth, A.3
Bain, D.4
-
24
-
-
15444361736
-
Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial
-
Ling W., Charuvastra C., Collins J., Batki S., Brown L.S., Kintaudi P., Wesson D.R., McNicholas L., Tusel D.J., Malkerneker U., Renner J.A., Santos E., Casadonte P., Fye C., Stine S., Wang R.I., Segal D. Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. Addiction 1998, 93:475-486.
-
(1998)
Addiction
, vol.93
, pp. 475-486
-
-
Ling, W.1
Charuvastra, C.2
Collins, J.3
Batki, S.4
Brown, L.S.5
Kintaudi, P.6
Wesson, D.R.7
McNicholas, L.8
Tusel, D.J.9
Malkerneker, U.10
Renner, J.A.11
Santos, E.12
Casadonte, P.13
Fye, C.14
Stine, S.15
Wang, R.I.16
Segal, D.17
-
25
-
-
0036768067
-
Buprenorphine: blending practice and research
-
Ling W., Smith D. Buprenorphine: blending practice and research. J. Subst. Abuse Treat. 2002, 23:87-92.
-
(2002)
J. Subst. Abuse Treat.
, vol.23
, pp. 87-92
-
-
Ling, W.1
Smith, D.2
-
26
-
-
57049118462
-
Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty
-
Mark T., Kassed C., Vandivort-Warren R., Levit K., Kranzler H. Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty. Drug Alcohol Depend. 2009, 99:345-349.
-
(2009)
Drug Alcohol Depend.
, vol.99
, pp. 345-349
-
-
Mark, T.1
Kassed, C.2
Vandivort-Warren, R.3
Levit, K.4
Kranzler, H.5
-
27
-
-
84155160614
-
-
SAMHSA Clinical Guidelines for the use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol, 40. SMA 04-3939. Rockville, MD.
-
McNicholas, L., 2004. SAMHSA Clinical Guidelines for the use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol, 40. SMA 04-3939. Rockville, MD.
-
(2004)
-
-
McNicholas, L.1
-
28
-
-
0021952114
-
Behavioral pharmacology of buprenorphine
-
Mello N., Mendelson J. Behavioral pharmacology of buprenorphine. Drug Alcohol Depend. 1985, 14:283-303.
-
(1985)
Drug Alcohol Depend.
, vol.14
, pp. 283-303
-
-
Mello, N.1
Mendelson, J.2
-
29
-
-
0023726538
-
Progressive ratio performance maintained by buprenorphine, heroin and methadone in macaque monkeys
-
Mello N., Lukas S., Bree M., Mendelson J. Progressive ratio performance maintained by buprenorphine, heroin and methadone in macaque monkeys. Drug Alcohol Depend. 1988, 21:81-97.
-
(1988)
Drug Alcohol Depend.
, vol.21
, pp. 81-97
-
-
Mello, N.1
Lukas, S.2
Bree, M.3
Mendelson, J.4
-
30
-
-
70449604853
-
Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland
-
Mitchell S., Kelly S., Brown B., Reisinger H., Peterson J., Ruhf A., Agar M., O'Grady K., Schwartz R. Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland. Am. J. Addict. 2009, 18:346-355.
-
(2009)
Am. J. Addict.
, vol.18
, pp. 346-355
-
-
Mitchell, S.1
Kelly, S.2
Brown, B.3
Reisinger, H.4
Peterson, J.5
Ruhf, A.6
Agar, M.7
O'Grady, K.8
Schwartz, R.9
-
31
-
-
70449652165
-
Diversion of buprenorphine/naloxone coformulated tablets in a region with high prescribing prevalence
-
Monte A., Mandell T., Wilford B., Tennyson J., Boyer E. Diversion of buprenorphine/naloxone coformulated tablets in a region with high prescribing prevalence. J. Addict. Dis. 2009, 28:226-231.
-
(2009)
J. Addict. Dis.
, vol.28
, pp. 226-231
-
-
Monte, A.1
Mandell, T.2
Wilford, B.3
Tennyson, J.4
Boyer, E.5
-
32
-
-
84855593299
-
-
NFLIS (National Forensic Laboratory Information System). Office of Diversion Control, Drug Enforcement Agency, US Department of Justice, Washington, DC.
-
NFLIS (National Forensic Laboratory Information System). Office of Diversion Control, Drug Enforcement Agency, US Department of Justice, Washington, DC. http://www.deadiversion.usdoj.gov/nflis/index.html.
-
-
-
-
33
-
-
0023729557
-
Buprenorphine abuse among opiate addicts
-
O'Connor J., Maloney E., Travers R., Campbell A. Buprenorphine abuse among opiate addicts. Br. J. Addict. 1988, 83:1083-1087.
-
(1988)
Br. J. Addict.
, vol.83
, pp. 1083-1087
-
-
O'Connor, J.1
Maloney, E.2
Travers, R.3
Campbell, A.4
-
34
-
-
33748776537
-
Increasing deaths from opioid analgesics in the United States
-
Paulozzi L., Budnitz D., Xi Y. Increasing deaths from opioid analgesics in the United States. Drug Saf. 2006, 15:618-627.
-
(2006)
Drug Saf.
, vol.15
, pp. 618-627
-
-
Paulozzi, L.1
Budnitz, D.2
Xi, Y.3
-
35
-
-
33845327826
-
Opioid analgesics and rates of fatal drug poisoning in the United States
-
Paulozzi L., Ryan G. Opioid analgesics and rates of fatal drug poisoning in the United States. Am. J. Prev. Med. 2006, 31:506-511.
-
(2006)
Am. J. Prev. Med.
, vol.31
, pp. 506-511
-
-
Paulozzi, L.1
Ryan, G.2
-
36
-
-
0027203690
-
The misuse of buprenorphine and a buprenorphine-naloxone combination in Wellington, New Zealand
-
Robinson G., Dukes P., Robinson B., Cooke R., Mahoney G. The misuse of buprenorphine and a buprenorphine-naloxone combination in Wellington, New Zealand. Drug Alcohol Depend. 1993, 33:81-86.
-
(1993)
Drug Alcohol Depend.
, vol.33
, pp. 81-86
-
-
Robinson, G.1
Dukes, P.2
Robinson, B.3
Cooke, R.4
Mahoney, G.5
-
37
-
-
34548433490
-
Abuse of buprenorphine in the United States: 2003-2005
-
Smith M., Bailey J., Woody G., Kleber H. Abuse of buprenorphine in the United States: 2003-2005. J. Addict. Dis. 2007, 26:107-111.
-
(2007)
J. Addict. Dis.
, vol.26
, pp. 107-111
-
-
Smith, M.1
Bailey, J.2
Woody, G.3
Kleber, H.4
-
38
-
-
0026666987
-
Cases of buprenorphine abuse in India
-
Singh R., Mattoo S., Malhotra A., Varma V. Cases of buprenorphine abuse in India. Acta Psychiatr. Scand. 1992, 86:46-48.
-
(1992)
Acta Psychiatr. Scand.
, vol.86
, pp. 46-48
-
-
Singh, R.1
Mattoo, S.2
Malhotra, A.3
Varma, V.4
-
39
-
-
84155172254
-
-
TEDS. United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. Treatment Episode Data Set-Admissions (TEDS-A), 2007 [Computer file]. ICPSR21540-v4. Inter-university Consortium for Political and Social Research [distributor], Ann Arbor, MI (22.04.10).
-
TEDS, 2007. United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. Treatment Episode Data Set-Admissions (TEDS-A), 2007 [Computer file]. ICPSR21540-v4. Inter-university Consortium for Political and Social Research [distributor], Ann Arbor, MI (22.04.10).
-
(2007)
-
-
-
40
-
-
84855607276
-
-
TEDS. The TEDS report: characteristics of substance abuse treatment admissions reporting primary abuse of prescription pain relievers: 1998 and 2008. (23.09.10).
-
TEDS, 2010. The TEDS report: characteristics of substance abuse treatment admissions reporting primary abuse of prescription pain relievers: 1998 and 2008. (23.09.10). http://oas.samhsa.gov/2k10/230/230PainRelvr2k10.htm.
-
(2010)
-
-
-
41
-
-
0028318472
-
Clinical pharmacology of buprenorphine: ceiling effects at high doses
-
Walsh S., Preston K., Stitzer M., Cone E., Bigelow G. Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin. Pharmacol. Ther. 1994, 55:569-580.
-
(1994)
Clin. Pharmacol. Ther.
, vol.55
, pp. 569-580
-
-
Walsh, S.1
Preston, K.2
Stitzer, M.3
Cone, E.4
Bigelow, G.5
-
42
-
-
0029070494
-
Acute administration of buprenorphine in humans: partial agonist and blockage effect
-
Walsh S., Preston K., Bigelow G., Stitzer M. Acute administration of buprenorphine in humans: partial agonist and blockage effect. J. Pharmacol. Exp. Ther. 1995, 274:361-372.
-
(1995)
J. Pharmacol. Exp. Ther.
, vol.274
, pp. 361-372
-
-
Walsh, S.1
Preston, K.2
Bigelow, G.3
Stitzer, M.4
-
43
-
-
0037987962
-
The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic
-
Walsh S., Eissenberg T. The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic. Drug Alcohol Depend. 2003, 70:S13-S27.
-
(2003)
Drug Alcohol Depend.
, vol.70
-
-
Walsh, S.1
Eissenberg, T.2
-
44
-
-
0035341938
-
The effects of chronic morphine on behavior reinforced by several opioids or by cocaine in rhesus monkeys
-
Winger G., Woods J. The effects of chronic morphine on behavior reinforced by several opioids or by cocaine in rhesus monkeys. Drug Alcohol Depend. 2001, 62:181-189.
-
(2001)
Drug Alcohol Depend.
, vol.62
, pp. 181-189
-
-
Winger, G.1
Woods, J.2
|